This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woo, P. C. Y. Articles by Yuen, K.-y. Search for Related Content PubMed PubMed Citation Articles by Woo, P. C. Y. Articles by Yuen, K.-y.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, July 2004, p. 665-668, Vol. 11, No. 4
1071-412X/04/$08.00+0     DOI: 10.1128/CDLI.11.4.665-668.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Longitudinal Profile of Immunoglobulin G (IgG), IgM, and IgA Antibodies against the Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in Patients with Pneumonia Due to the SARS Coronavirus

Patrick C. Y. Woo,^1, Susanna K. P. Lau,^1, Beatrice H. L. Wong,¹ Kwok-hung Chan,¹ Chung-ming Chu,² Hoi-wah Tsoi,¹ Yi Huang,¹ J. S. Malik Peiris,¹ and Kwok-yung Yuen^1*

Department of Microbiology, The University of Hong Kong,¹ Division of Respiratory Medicine, Department of Medicine, United Christian Hospital, Hong Kong²

Received 6 February 2004/ Returned for modification 31 March 2004/ Accepted 8 April 2004

By using a recombinant severe acute respiratory syndrome coronavirus (SARS-CoV) nucleocapsid protein-based enzyme-linked immunosorbent assay (ELISA) and serum specimens serially collected (from day 0 to day 240 after symptom onset) from patients with pneumonia due to SARS-CoV, we analyzed the longitudinal profiles of immunoglobulin G (IgG), IgM, and IgA antibodies against the SARS-CoV nucleocapsid protein in patients with pneumonia due to SARS-CoV. For IgG, the median optical density at 450 nm (OD₄₅₀) turned positive at day 17 and a biphasic response was observed. At day 240, all patients were still positive for anti-nucleocapsid protein IgG antibody. For IgM, the median OD₄₅₀ turned positive at day 20.5, peaked at about day 80, and fell to below the baseline level at about day 180. At day 240, 36% of the patients were still positive for anti-nucleocapsid protein IgM antibody. For IgA, the median OD₄₅₀ turned positive at day 17, peaked at about day 50, and fell to below the baseline level at about day 180. At day 240, 36% of the patients were still positive for anti-nucleocapsid protein IgA antibody. The time of seroconversion detected by the recombinant SARS-CoV nucleocapsid protein-based ELISA and that detected by indirect immunofluorescence assay were similar. The median times of seroconversion for IgG, IgM, and IgA detected by the indirect immunofluorescence assay were 17 days (17 days by ELISA), 16.5 days (20.5 days by ELISA), and 17.5 days (17 days by ELISA), respectively, after disease onset. One, four, and one of the six patients who died did not produce any IgG, IgM, and IgA antibodies against the nucleocapsid protein of SARS-CoV, respectively, although these antibodies were detected in all six patients by the indirect immunofluorescence assay. Further studies should be performed to see whether SARS-CoV nucleocapsid protein antibody positivity has any prognostic significance.

P.C.Y.W. and S.K.P.L. contributed the same to the manuscript.

This article has been cited by other articles:

• Zhu, H., Hu, S., Jona, G., Zhu, X., Kreiswirth, N., Willey, B. M., Mazzulli, T., Liu, G., Song, Q., Chen, P., Cameron, M., Tyler, A., Wang, J., Wen, J., Chen, W., Compton, S., Snyder, M. (2006). Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray.. Proc. Natl. Acad. Sci. USA 103: 4011-4016 [Abstract] [Full Text]  
• Chang, S.-C., Wang, J.-T., Huang, L.-M., Chen, Y.-C., Fang, C.-T., Sheng, W.-H., Wang, J.-L., Yu, C.-J., Yang, P.-C. (2005). Longitudinal Analysis of Severe Acute Respiratory Syndrome (SARS) Coronavirus-Specific Antibody in SARS Patients. CVI 12: 1455-1457 [Abstract] [Full Text]  
• Liang, Y., Wan, Y., Qiu, L.-w., Zhou, J., Ni, B., Guo, B., Zou, Q., Zou, L., Zhou, W., Jia, Z., Che, X.-y., Wu, Y. (2005). Comprehensive Antibody Epitope Mapping of the Nucleocapsid Protein of Severe Acute Respiratory Syndrome (SARS) Coronavirus: Insight into the Humoral Immunity of SARS. Clin. Chem. 51: 1382-1396 [Abstract] [Full Text]  
• Woo, P. C. Y., Lau, S. K. P., Wong, B. H. L., Tsoi, H.-w., Fung, A. M. Y., Kao, R. Y. T., Chan, K.-h., Peiris, J. S. M., Yuen, K.-y. (2005). Differential Sensitivities of Severe Acute Respiratory Syndrome (SARS) Coronavirus Spike Polypeptide Enzyme-Linked Immunosorbent Assay (ELISA) and SARS Coronavirus Nucleocapsid Protein ELISA for Serodiagnosis of SARS Coronavirus Pneumonia. J. Clin. Microbiol. 43: 3054-3058 [Abstract] [Full Text]  
• Lau, S. K. P., Woo, P. C. Y., Wong, B. H. L., Tsoi, H.-W., Woo, G. K. S., Poon, R. W. S., Chan, K.-H., Wei, W. I., Peiris, J. S. M., Yuen, K.-Y. (2004). Detection of Severe Acute Respiratory Syndrome (SARS) Coronavirus Nucleocapsid Protein in SARS Patients by Enzyme-Linked Immunosorbent Assay. J. Clin. Microbiol. 42: 2884-2889 [Abstract] [Full Text]